the virus that causes COVID-19, have a wide variety of autoantibodies up to six months after they have fully recovered. Prior to this study, researchers knew that severe cases of COVID-19 can stress the immune system so much that autoantibodies are produced. This study is the first to rep...
covid-19cytokine stormIntroduction SARS-CoV-2, the causative agent of COVID-19, attacks the immune system causing an exaggerated and uncontrolled release of pro-inflammatory mediators (cytokine storm). Recent studies propose an active role of coagulation disorders in disease progression. This hyper...
The immune system's fight against the Coronavirus; convalescent plasma from Covid-19 survivors may be used to treat patients and protect those at risk Severe Acute Respiratory Syndrome (SARS) and Coronavirus (Covid-19) outbreak are creating emergency in public health sector. Using antiviral, antim...
If yourimmune systemcan’t subdue(制服) COVID-19 in the first week or so, the virus may move down into your lungs. There, it attacks cells that line them. Fluid(液体) and mucus(黏液)build upand make it harder...
PCR has revealed the presence of COVID-19 in cerebrospinal fluid, which may also stimulate encephalitis [74]. In some cases, COVID-19 has incited the development of Guillain-Barré syndrome (GBS), where the body’s immune system attacks nerves, leading to flaccid paralysis. The virus has ...
CoronaVac uses an inactivated whole virus. When people receive the vaccine, their immune system attacks the harmless form of the virus by producing antibodies to fight it off, leading to immunity. Developed by Sinovac Life Sciences, the vaccine—which can be stored and transported at 2-8°C—...
The researchers discovered that among people who had had COVID-19 in the past, the T cell response expanded after vaccination to recognise more regions of the COVID-19 spike protein—which attacks the immune system and causes severe disease. This means, even in those already infected, vaccinati...
If the virus mutates very fast the next time it infects you, the immune system might not be capable of recognizing it again because it now looks different. "And then you could get a re-infection. That is a theoretical possibility. It does happen." Another ar...
classifying azithromycin as asenolytic drugthat selectively attacks and kills senescent cells with an efficiency of almost 97% [30]. Although there is no direct evidence of the efficacy of azithromycin in treating COVID-19, some scientific bodies have suggested that the antibacterial properties of az...
If your immune system can't subdue COVID-19 in the first week or so, the virus may move down into your lungs. There, it attacks cells that line them. Fluid and mucus build up and make it harder to get oxygen to your blood. It gets tough to breathe. This is pneumonia. Most people...